Reperio Health Changes the Trajectory of At-Home Health Care with Patent for a First-of-its-Kind Biometric Screening Technology

The patent, granted on November 1, highlights the Portland-based health tech as a trusted solution for chronic disease management and prevention

Reperio Health announced today that their company secured its first patent — granted on November 1, 2022, by the U.S. Patent and Trademark Office — for the technology that powers the company’s biometric home-based screening service. Reperio’s flagship at-home screening kit utilizes FDA-cleared medical devices that enable users to measure key health metrics from the comfort of their home. The company’s now patented Bluetooth-integrated technology allows users to get their results instantly instead of waiting weeks for traditional lab results.

Current studies suggest 60% of Americans live with at least one chronic health condition such as diabetes or hypertension, which raises their risk for sickness and preventable events like heart attacks. Chronic diseases cost the U.S. an estimated $3.7 trillion per year, including lost economic productivity. Health metrics derived from Reperio’s kit can help employers, payers and other healthcare stakeholders gain comprehensive insight into the overall health and well-being of their constituents and proactively mitigate costly chronic diseases.

Unlike a traditional lab setting or mail-in blood cards, results from Reperio’s at-home screenings provide instant results about BMI, cholesterol, blood sugar levels and more. Accessed from the comfort of their home, users can leverage this insight to quickly identify out-of-range results and receive advice on when to follow-up with their primary care provider. The medical devices in the Reperio screening kit are Bluetooth-connected, so information is processed immediately and securely viewable within the accompanying app.

“We developed our at-home screening kits to enable consumers to self-screen multiple metrics and receive results in as little as 30 minutes,” says Travis Rush, Reperio’s CEO and co-founder. “We are proud that our patent solidifies Reperio’s position as an industry leader and innovator of health screening tools. But more importantly, we want to offer a solution to industry inefficiencies that plague our health system. What we’ve created will drastically help to relieve the strain on overworked medical professionals and eliminate the hassles of scheduling and traveling to appointments at traditional labs or pharmacies, which ultimately leads to procrastination and undiagnosed underlying health conditions and can severely impact patient outcomes.”

Dr. Alex Marsh, Chief Medical Officer of Reperio and a practicing emergency physician, added that regular screening for chronic conditions can keep individuals healthy and out of the emergency department.

“During the pandemic, many patients were delaying care and during that time, a lot of undetected chronic diseases were left to fester. For example, many patients don’t realize they have a health condition like diabetes—which affects one in four young adults—until they end up in the hospital emergency room because they are showing serious, or even life-threatening, symptoms of that disease,” says Dr. Marsh. “Expanding the use of solutions like Reperio can help to prevent these types of visits by raising awareness of problematic, yet common, health issues.”

To learn more about Reperio’s at-home screening kit and the future of preventive screening, visit https://www.reperiohealth.com/screening-resources/why-reperios-patent-for-its-biometric-at-home-screening-tool-is-a-big-deal-for-patient-engagement-and-chronic-disease-prevention

About Reperio Health

Reperio is the only at-home health assessment that provides comprehensive results immediately via the company’s Bluetooth-connected technology. The company’s patented health solution enables private individuals, as well as company employees and patients of telehealth services or medical clinics and hospitals to perform biometric screenings at their convenience while in the comfort of their own home with 24/7 live support. For more information, visit www.reperiohealth.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230104005154/en/